Default Mode Network quantitative diffusion and resting-state functional magnetic resonance imaging correlates in sporadic Creutzfeldt-Jakob disease.


Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
09 2022
Historique:
revised: 14 04 2022
received: 22 01 2021
accepted: 01 05 2022
pubmed: 7 6 2022
medline: 17 8 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

Grey matter involvement is a well-known feature in sporadic Creutzfeldt-Jakob disease (sCJD), yet precise anatomy-based quantification of reduced diffusivity is still not fully understood. Default Mode Network (DMN) areas have been recently demonstrated as selectively involved in sCJD, and functional connectivity has never been investigated in prion diseases. We analyzed the grey matter involvement using a quantitatively multi-parametric MRI approach. Specifically, grey matter mean diffusivity of 37 subjects with sCJD was compared with that of 30 age-matched healthy controls with a group-wise approach. Differences in mean diffusivity were also examined between the cortical (MM(V)1, MM(V)2C, and VV1) and subcortical (VV2 and MV2K) subgroups of sCJD for those with autopsy data available (n = 27, 73%). We also assessed resting-state functional connectivity of both ventral and dorsal components of DMN in a subset of subject with a rs-fMRI dataset available (n = 17). Decreased diffusivity was predominantly present in posterior cortical regions of the DMN, but also outside of the DMN in temporal areas and in a few limbic and frontal areas, in addition to extensive deep nuclei involvement. Both subcortical and cortical sCJD subgroups showed decreased diffusivity subcortically, whereas only the cortical type expressed significantly decreased diffusivity cortically, mainly in parietal, occipital, and medial-inferior temporal cortices bilaterally. Interestingly, we found abnormally increased connectivity in both dorsal and ventral components of the DMN in sCJD subjects compared with healthy controls. The significance and possible utility of functional imaging as a biomarker for tracking disease progression in prion disease needs to be explored further.

Identifiants

pubmed: 35662331
doi: 10.1002/hbm.25945
pmc: PMC9374887
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4158-4173

Subventions

Organisme : NIA NIH HHS
ID : R01 AG031189
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG032289
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062422
Pays : United States
Organisme : NIA NIH HHS
ID : K23 AG031861
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG032289
Pays : United States

Informations de copyright

© 2022 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

Références

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1509-1525
pubmed: 29736698
J Biol Chem. 2014 Jul 18;289(29):19841-9
pubmed: 24860095
Brain. 2012 Dec;135(Pt 12):3699-711
pubmed: 23195207
J Neurophysiol. 2011 Nov;106(5):2322-45
pubmed: 21795627
Neurology. 2013 Feb 26;80(9):814-23
pubmed: 23390180
Neuroimage. 1999 Sep;10(3 Pt 1):233-60
pubmed: 10458940
Cerebellum. 2009 Sep;8(3):373-81
pubmed: 19408064
J Neurosci. 2012 Jan 4;32(1):215-22
pubmed: 22219283
Neurology. 2009 Jun 9;72(23):1994-2001
pubmed: 19506221
Neuron. 2012 Mar 22;73(6):1216-27
pubmed: 22445348
Neurology. 2011 Feb 8;76(6):511-7
pubmed: 21228297
J Gen Virol. 1992 Jul;73 ( Pt 7):1637-44
pubmed: 1629695
Neuron. 2010 Feb 25;65(4):550-62
pubmed: 20188659
Brain. 2011 Dec;134(Pt 12):3470-9
pubmed: 22075069
Neuropathol Appl Neurobiol. 2000 Feb;26(1):41-54
pubmed: 10736066
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Hum Brain Mapp. 2022 Sep;43(13):4158-4173
pubmed: 35662331
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20069-74
pubmed: 19903877
Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1612-38
pubmed: 26633779
Neurosci Lett. 2009 Aug 21;460(1):6-10
pubmed: 19463891
BJPsych Open. 2015 Nov 9;1(2):139-148
pubmed: 27703739
Nat Rev Neurosci. 2015 Feb;16(2):109-20
pubmed: 25588378
Neuroimage Clin. 2014 Nov 29;7:142-54
pubmed: 25610776
AJNR Am J Neuroradiol. 2006 Sep;27(8):1755-9
pubmed: 16971630
AJNR Am J Neuroradiol. 2003 May;24(5):908-15
pubmed: 12748093
Brain. 2016 Feb;139(Pt 2):547-62
pubmed: 26586695
AJNR Am J Neuroradiol. 2006 Aug;27(7):1459-62
pubmed: 16908558
Ann Clin Transl Neurol. 2021 Jun;8(6):1183-1199
pubmed: 33949799
Neuroreport. 2013 Aug 21;24(12):657-62
pubmed: 23839257
Neuron. 2012 Mar 22;73(6):1204-15
pubmed: 22445347
AJNR Am J Neuroradiol. 2002 Aug;23(7):1164-72
pubmed: 12169476
Neurology. 2009 Apr 21;72(16):1425-31
pubmed: 19380702
Brain Connect. 2013;3(4):353-62
pubmed: 23627661
Semin Neurol. 2017 Oct;37(5):510-537
pubmed: 29207412
Arch Neurol. 1996 Sep;53(9):913-20
pubmed: 8815857
Neuron. 2009 Apr 16;62(1):42-52
pubmed: 19376066
Cortex. 2013 Jul-Aug;49(7):1856-73
pubmed: 23092697
Ann Neurol. 1999 Aug;46(2):224-33
pubmed: 10443888
Neuropathology. 2017 Apr;37(2):174-188
pubmed: 28028861
Brain. 2006 Sep;129(Pt 9):2278-87
pubmed: 16816392
Brain. 2014 Dec;137(Pt 12):3339-54
pubmed: 25367029
Neuroscience. 2000;97(4):715-26
pubmed: 10842016
Brain. 2009 Oct;132(Pt 10):2659-68
pubmed: 19773352
Commun Biol. 2019 Oct 10;2:370
pubmed: 31633061
Ann Neurol. 1986 Nov;20(5):597-602
pubmed: 3539001
Neuroimage Clin. 2014 Jan 31;4:426-35
pubmed: 24624328
Acta Neuropathol. 2011 Jan;121(1):91-112
pubmed: 21107851
Curr Opin Neurol. 2012 Dec;25(6):721-6
pubmed: 23108252
Neurobiol Aging. 2013 Feb;34(2):419-27
pubmed: 22608240
Neurology. 2007 Nov 6;69(19):1881-7
pubmed: 17984457
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Neurology. 2004 Aug 10;63(3):443-9
pubmed: 15304574
Nat Rev Neurol. 2014 Nov;10(11):620-33
pubmed: 25287597
Alzheimers Res Ther. 2012 Mar 15;4(2):8
pubmed: 22423634
Front Aging Neurosci. 2013 Jul 15;5:30
pubmed: 23874298
AJR Am J Roentgenol. 2005 Feb;184(2):560-6
pubmed: 15671380
Neurology. 2011 May 17;76(20):1711-9
pubmed: 21471469
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1279-84
pubmed: 19164577
Brain. 2010 May;133(Pt 5):1352-67
pubmed: 20410145
Lancet Neurol. 2017 Apr;16(4):323-332
pubmed: 28238712
J Alzheimers Dis. 2016 Nov 1;55(1):431-443
pubmed: 27662320
Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):82-87
pubmed: 19266702
AJNR Am J Neuroradiol. 2007 Jun-Jul;28(6):1114-8
pubmed: 17569970
Neuroimage Clin. 2021;30:102523
pubmed: 33636540
Neuroimage. 2009 Oct 15;48(1):63-72
pubmed: 19573611
Brain. 2002 Nov;125(Pt 11):2558-66
pubmed: 12390980
JAMA Neurol. 2020 Sep 1;77(9):1141-1149
pubmed: 32478816
Neurology. 2011 Nov 1;77(18):1674-83
pubmed: 22013183
Neuroimage. 2013 Jan 1;64:240-56
pubmed: 22926292
Neurology. 1999 Dec 10;53(9):2173-6
pubmed: 10599800
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7209-14
pubmed: 19357304
AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1551-62
pubmed: 15956529
J Neurol. 2013 Feb;260(2):498-506
pubmed: 22968768
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12788-93
pubmed: 22807481
Nat Rev Neurosci. 2010 Mar;11(3):155-9
pubmed: 20029438
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Neuron. 2016 Feb 3;89(3):433-48
pubmed: 26844828
Ann N Y Acad Sci. 2008 Mar;1124:1-38
pubmed: 18400922
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494
JAMA Neurol. 2016 Jan;73(1):76-84
pubmed: 26569479
Acta Neuropathol. 2020 Aug;140(2):169-181
pubmed: 32535770
Brain. 2014 Jan;137(Pt 1):12-32
pubmed: 23869106
Ann Neurol. 2013 May;73(5):603-16
pubmed: 23536287
AJNR Am J Neuroradiol. 2010 Jan;31(1):49-54
pubmed: 19749217
Lancet Neurol. 2021 Mar;20(3):235-246
pubmed: 33609480
J Neurophysiol. 2011 Sep;106(3):1125-65
pubmed: 21653723
Neurobiol Aging. 2015 Oct;36(10):2678-86
pubmed: 26242705
Ann Neurol. 2021 Mar;89(3):560-572
pubmed: 33274461
Brain. 2009 Oct;132(Pt 10):2680-7
pubmed: 19321460

Auteurs

Matteo Paoletti (M)

Memory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.
Department of Neuroradiology, IRCCS Mondino Foundation, Pavia, Italy.

Eduardo Caverzasi (E)

Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Maria Luisa Mandelli (ML)

Memory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.

Jesse A Brown (JA)

Memory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.

Roland G Henry (RG)

Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Graduate Group in Bioengineering, University of California San Francisco, San Francisco, California, USA.
Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.

Bruce L Miller (BL)

Memory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.

Howard J Rosen (HJ)

Memory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.

Stephen J DeArmond (SJ)

Department of Pathology, University of California, San Francisco, California, USA.

Stefano Bastianello (S)

Department of Neuroradiology, IRCCS Mondino Foundation, Pavia, Italy.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

William W Seeley (WW)

Memory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.
Department of Pathology, University of California, San Francisco, California, USA.

Michael D Geschwind (MD)

Memory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH